VU University Medical Center, Amsterdam, released results of a 5 year – 45000 patient – study comparing HPV DNA testing to traditional pap smear testing. The study showed HPV DNA testing was more accurate in identifying cancer precursors the Cytology alone.
The results will be published in the January 2012 issue of The Lancet Oncology .
“Implementation of HPV DNA testing in cervical screening leads to earlier detection of clinically relevant CIN grade 2 or worse, which when adequately treated, improves protection against CIN grade 3 or worse and cervical cancer,” according to researchers.
For women, this means that the inclusion of a HPV DNA test along with the annual pap smear can help improve accurate diagnosis and early treatment of cervical cancers – saving lives.
The VU University Medical Center research teamemphasized that these results support the implementation of HPV DNA testing as part of the annual GYN health program for women over the age of 30.
Nordqvist, Christian “HPV DNA Testing Advized for Females Over 30” in Medical News Today Dec 15, 2011. http://www.medicalnewstoday.com/articles/239282.php
Dorien C Rijkaart MD, Johannes Berkhof PhD, Lawrence Rozendaal MD, Folkert J van Kemenade MD, Nicole WJ Bulkmans MD, Daniëlle AM Heideman PhD “Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial” in The Lancet Oncology Vol 13 No. 1 pp78-88. http://www.thelancet.com/search/results?searchTerm=HPV+DNA+Testing&fieldName=AllFields&journalFromWhichSearchStarted=